NCT00282828View on ClinicalTrials.gov

Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

397

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Social Phobia
Interventions
DRUG

Sertraline

DRUG

Venlafaxine

DRUG

Placebo

DRUG

Clonazepam

Trial Locations (3)

92093

University of California San Diego, La Jolla

02116

Center for Anxiety and Traumatic Stress Disorders, Boston

L8N 3Z5

McMaster University Medical Centre Anxiety Disorders Clinic, Hamilton

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Massachusetts General Hospital

OTHER

NCT00282828 - Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder | Biotech Hunter | Biotech Hunter